UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis

Proteomics (Weinheim), 2015-07, Vol.15 (13), p.2318-2331

2015

Volltextzugriff (PDF)

Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy

Current protein & peptide science, 2013-12, Vol.14 (8), p.680-697

2013

Volltextzugriff (PDF)

Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin

Proteomics (Weinheim), 2013-08, Vol.13 (15), p.2312-2323

2013

Volltextzugriff (PDF)

Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers

Molecules (Basel, Switzerland), 2015-06, Vol.20 (6), p.11317-11344

2015

Volltextzugriff (PDF)

Comparative Testis Tissue Proteomics Using 2-Dye Versus 3-Dye DIGE Analysis

Methods in molecular biology (Clifton, N.J.), 2018, Vol.1664, p.185

Holland, Ashling

2018

Volltextzugriff (PDF)

Comparative profiling of the sperm proteome

Proteomics (Weinheim), 2015-02, Vol.15 (4), p.632-648

2015

Volltextzugriff (PDF)

ECSIT is a critical limiting factor for cardiac function

JCI insight, 2021-06, Vol.6 (12)

2021

Volltextzugriff (PDF)

Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy

BioMed research international, 2014-01, Vol.2014 (2014), p.1-15

2014

Volltextzugriff (PDF)

Proteomic profiling of the contractile apparatus from skeletal muscle

Expert review of proteomics, 2013-06, Vol.10 (3), p.239-257

2013

Volltextzugriff (PDF)

Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis

Proteomics (Weinheim), 2016-01, Vol.16 (2), p.345-366

2016

Volltextzugriff (PDF)

PGN-EDODM1: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Myotonic Dystrophy Type 1 (DM1) (S48.001)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

PGN-EDO51: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD) (P3-8.002)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Design of a Phase 1, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of PGN-EDODM1 in Adult Participants with Myotonic Dystrophy Type 1 (DM1) (P6-8.004)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Design of a phase 2 clinical program for the development of PGN-EDO51 in participants with duchenne muscular dystrophy (DMD)

Journal of the neurological sciences, 2023-12, Vol.455, p.121120, Article 121120

2023

Volltextzugriff (PDF)

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice

The Journal of clinical investigation, 2019-11, Vol.129 (11), p.4739-4744

2019

Volltextzugriff (PDF)

PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy Volunteers (P3-8.004)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Positive results from a first-in-human study supporting continued development of PGN-EDO51 for the treatment of duchenne muscular dystrophy (DMD)

Journal of the neurological sciences, 2023-12, Vol.455, p.121117, Article 121117

2023

Volltextzugriff (PDF)

Front cover: Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis

Proteomics (Weinheim), 2016-01, Vol.16 (2), p.NA

2016

Volltextzugriff (PDF)

Proteomic identification of muscle-associated biomarkers of amyotrophic lateral sclerosis using the wobbler mouse model of primary motor neuronopathy

Journal of integrated OMICS, 2014-12, Vol.4 (2)

2014

Volltextzugriff (PDF)

Peptide-conjugated oligonucleotides evoke longlasting myotonic dystrophy correction in patient-derived cells and mice

The Journal of clinical investigation, 2019-11, Vol.129 (11), p.4739-4744

2019

Volltextzugriff (PDF)

Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients

Journal of medical microbiology, 2014-02, Vol.63 (2), p.258-262

2014

Volltextzugriff (PDF)

Comparative Proteomics for Studying Muscular Dystrophy: Intrinsic Biological and Analytical Issues Associated with the Systematic Utilization of Tissue Specimens

Journal of proteomics & bioinformatics, 2014, Vol.1 (s10)

2014

Volltextzugriff (PDF)

Pathoproteomics of testicular tissue deficient in the GARP component VPS54: The wobbler mouse model of globozoospermia

Proteomics (Weinheim), 2014-04, Vol.14 (7-8), p.839-852

2014

Volltextzugriff (PDF)

Mass Spectrometry-Based Identification of Muscle-Associated and Muscle-Derived Proteomic Biomarkers of Dystrophinopathies

Journal of Neuromuscular Diseases, 2014, Vol.1 (1), p.15-40

2014

Volltextzugriff (PDF)

Intricate effects of primary motor neuronopathy on contractile proteins and metabolic muscle enzymes as revealed by label-free mass spectrometry

Bioscience reports, 2014-07, Vol.34 (4)

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)
Dissertationen
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis

Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy

Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin

Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers

Comparative Testis Tissue Proteomics Using 2-Dye Versus 3-Dye DIGE Analysis

Comparative profiling of the sperm proteome

ECSIT is a critical limiting factor for cardiac function

Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy

Proteomic profiling of the contractile apparatus from skeletal muscle

Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis

PGN-EDODM1: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Myotonic Dystrophy Type 1 (DM1) (S48.001)

PGN-EDO51: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD) (P3-8.002)

Design of a Phase 1, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of PGN-EDODM1 in Adult Participants with Myotonic Dystrophy Type 1 (DM1) (P6-8.004)

Design of a phase 2 clinical program for the development of PGN-EDO51 in participants with duchenne muscular dystrophy (DMD)

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice

PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy Volunteers (P3-8.004)

Positive results from a first-in-human study supporting continued development of PGN-EDO51 for the treatment of duchenne muscular dystrophy (DMD)

Front cover: Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis

Proteomic identification of muscle-associated biomarkers of amyotrophic lateral sclerosis using the wobbler mouse model of primary motor neuronopathy

Peptide-conjugated oligonucleotides evoke longlasting myotonic dystrophy correction in patient-derived cells and mice

Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients

Comparative Proteomics for Studying Muscular Dystrophy: Intrinsic Biological and Analytical Issues Associated with the Systematic Utilization of Tissue Specimens

Pathoproteomics of testicular tissue deficient in the GARP component VPS54: The wobbler mouse model of globozoospermia

Mass Spectrometry-Based Identification of Muscle-Associated and Muscle-Derived Proteomic Biomarkers of Dystrophinopathies

Intricate effects of primary motor neuronopathy on contractile proteins and metabolic muscle enzymes as revealed by label-free mass spectrometry

Suchergebnisse filtern